These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 9180626)

  • 21. Angiotensin II receptor antagonist losartan has persistent effects on blood pressure in the young spontaneously hypertensive rat: lack of relation to vascular structure.
    Morton JJ; Beattie EC; MacPherson F
    J Vasc Res; 1992; 29(3):264-9. PubMed ID: 1387008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in SHR.
    Nunez E; Hosoya K; Susic D; Frohlich ED
    Hypertension; 1997 Jan; 29(1 Pt 2):519-24. PubMed ID: 9039153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of ANG II receptor antagonist on albuminuria and renal function in passive Heymann nephritis.
    Hutchinson FN; Webster SK
    Am J Physiol; 1992 Aug; 263(2 Pt 2):F311-8. PubMed ID: 1510124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of nitric oxide and angiotensin II in the regulation of sympathetic nerve activity in spontaneously hypertensive rats.
    Kumagai H; Averill DB; Khosla MC; Ferrario CM
    Hypertension; 1993 Apr; 21(4):476-84. PubMed ID: 8384603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin receptor blockers improve insulin signaling and prevent microvascular rarefaction in the skeletal muscle of spontaneously hypertensive rats.
    Rizzoni D; Pasini E; Flati V; Rodella LF; Paiardi S; Assanelli D; De Ciuceis C; Porteri E; Boari GE; Rezzani R; Speca S; Favero G; Martinotti S; Toniato E; Platto C; Agabiti-Rosei E
    J Hypertens; 2008 Aug; 26(8):1595-601. PubMed ID: 18622238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients.
    Goldberg MR; Bradstreet TE; McWilliams EJ; Tanaka WK; Lipert S; Bjornsson TD; Waldman SA; Osborne B; Pivadori L; Lewis G
    Hypertension; 1995 Jan; 25(1):37-46. PubMed ID: 7843751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism.
    Ohlstein EH; Gellai M; Brooks DP; Vickery L; Jugus J; Sulpizio A; Ruffolo RR; Weinstock J; Edwards RM
    J Pharmacol Exp Ther; 1992 Aug; 262(2):595-601. PubMed ID: 1501114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of losartan and enalapril on renal adaptation sodium restriction in rat.
    Jover B; Saladini D; Nafrialdi N; Dupont M; Mimran A
    Am J Physiol; 1994 Aug; 267(2 Pt 2):F281-8. PubMed ID: 8067389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roles of renal and vascular renin in spontaneous hypertension and switching of the mechanism upon nephrectomy. Lack of hypotensive effects of inhibition of renin, converting enzyme, and angiotensin II receptor blocker after bilateral nephrectomy.
    Inagami T; Murakami T; Higuchi K; Nakajo S
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):15S-22S. PubMed ID: 2009142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardioprotective effect of enalapril in renovascular and angiotensin II hypertension.
    Herizi A; Demeilliers B; Jover B; Mimran A
    Clin Exp Hypertens; 1997; 19(5-6):953-64. PubMed ID: 9247767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enalapril improves glucose tolerance in two rat models: a new hypertensive diabetic strain and a fructose-induced hyperinsulinaemic rat.
    Rosenthal T; Erlich Y; Rosenmann E; Grossman E; Cohen A
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S353-4. PubMed ID: 9072425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of angiotensin in pressure overload-induced hypertrophy in rats: effects of angiotensin-converting enzyme inhibitors, an AT1 receptor antagonist, and surgical reversal.
    Mohabir R; Young SD; Strosberg AM
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):291-9. PubMed ID: 7511760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The advantages of angiotensin II antagonism.
    Burnier M; Waeber B; Brunner HR
    J Hypertens Suppl; 1994 Jul; 12(2):S7-15. PubMed ID: 7965267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of involvement of bradykinin in the vascular sympathoinhibitory effects of angiotensin converting enzyme inhibitors in spontaneously hypertensive rats.
    Chauvin B; Richer C; Giudicelli JF
    Br J Pharmacol; 1995 Oct; 116(4):2229-36. PubMed ID: 8564253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of angiotensin II in the regulation of a novel vascular modulator, hepatocyte growth factor (HGF), in experimental hypertensive rats.
    Nakano N; Moriguchi A; Morishita R; Kida I; Tomita N; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Hypertension; 1997 Dec; 30(6):1448-54. PubMed ID: 9403566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.
    Schieffer B; Wirger A; Meybrunn M; Seitz S; Holtz J; Riede UN; Drexler H
    Circulation; 1994 May; 89(5):2273-82. PubMed ID: 8181153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of angiotensin II receptor antagonism and converting enzyme inhibition in the progression and regression of cardiac hypertrophy in rats.
    Linz W; Henning R; Schölkens BA
    J Hypertens Suppl; 1991 Dec; 9(6):S400-1. PubMed ID: 1840203
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril.
    Burdmann EA; Andoh TF; Nast CC; Evan A; Connors BA; Coffman TM; Lindsley J; Bennett WM
    Am J Physiol; 1995 Oct; 269(4 Pt 2):F491-9. PubMed ID: 7485533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute myocardial and vascular responses to specific angiotensin II antagonism in the spontaneously hypertensive rat.
    Cody RJ; Binkley PF; Haas GJ; Brown DM
    Am J Hypertens; 1995 May; 8(5 Pt 1):500-8. PubMed ID: 7662227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.